Not applicableUnknownNCT01815190What this trial is testingIgA-positive Versus IgA-negative Immune Complex VasculitisWho this might be right forCutaneous Vasculitis University Hospital Muenster 300
Early research (Phase 1)Looking for participantsNCT07236762What this trial is testingAn Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusLupus Nephritis (LN)Sjogren's Syndrome+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Large-scale testing (Phase 3)Active Not RecruitingNCT05248646What this trial is testingTrial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)Who this might be right forImmunoglobulin A Nephropathy Otsuka Pharmaceutical Development & Commercialization, Inc. 530
Early research (Phase 1)Looking for participantsNCT06285279What this trial is testingThe BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney DiseasesWho this might be right forLupus NephritisANCA-associated VasculitisMembranous Nephropathy - PLA2R Induced+1 more Nanjing University School of Medicine 24
Large-scale testing (Phase 3)UnknownNCT05631717What this trial is testingThe Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LNWho this might be right forSystemic Lupus ErythematosusLupus Nephritis The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Large-scale testing (Phase 3)Ended earlyNCT05679401What this trial is testingA Study With Imlifidase in Anti-GBM DiseaseWho this might be right forAnti-Glomerular Basement Membrane DiseaseAnti-Glomerular Basement Membrane Antibody DiseaseGoodpasture Syndrome+1 more Hansa Biopharma AB 50
Large-scale testing (Phase 3)Study completedNCT02457221What this trial is testingCompare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus NephritisWho this might be right forLupus Nephritis Astellas Pharma China, Inc. 314
Testing effectiveness (Phase 2)Study completedNCT02592798What this trial is testingPilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)Who this might be right forNephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease Bristol-Myers Squibb 36
Post-approval studies (Phase 4)UnknownNCT03218852What this trial is testingExtended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA NephropathyWho this might be right forIgA Nephropathy Guangdong Provincial People's Hospital 133
Not applicableLooking for participantsNCT05505500What this trial is testingInterview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.Who this might be right forFluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more University of Michigan 150
Testing effectiveness (Phase 2)Study completedNCT00007475What this trial is testingPermeability Factor in Focal Segmental GlomerulosclerosisWho this might be right forFocal Segmental Glomerulosclerosis National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Large-scale testing (Phase 3)Looking for participantsNCT07499700What this trial is testingA Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental GlomerulosclerosisWho this might be right forMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS) Bio-Thera Solutions 192
Large-scale testing (Phase 3)Looking for participantsNCT06858319What this trial is testingOpen-label Extension Study of Zigakibart in Adults With IgA Nephropathy.Who this might be right forKidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more Novartis Pharmaceuticals 220
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06674577What this trial is testingA Rollover Study to Evaluate the Long-Term Safety and Efficacy of AtaciceptWho this might be right forIgA Nephropathy (IgAN)Renal and Urinary DisordersBerger Disease Vera Therapeutics, Inc. 750
Very early researchLooking for participantsNCT07586267What this trial is testingCD19/BCMA UCAR-T for B Cell-Related Autoimmune DiseaseWho this might be right forAutoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more The Children's Hospital of Zhejiang University School of Medicine 15
Large-scale testing (Phase 3)Looking for participantsNCT06819826What this trial is testingSC0062 Capsule for the Treatment of IgA Nephropathy with ProteinuriaWho this might be right forIgA Nephropathy (IgAN) Biocity Biopharmaceutics Co., Ltd. 360
Testing effectiveness (Phase 2)Study completedNCT05834738What this trial is testingRandomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA NephropathyWho this might be right forIgA NephropathyImmunoglobulin A Nephropathy Novartis Pharmaceuticals 54
Large-scale testing (Phase 3)Ended earlyNCT02081183What this trial is testingEvaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus NephritisWho this might be right forLupus Nephritis Hoffmann-La Roche 16
Not applicableLooking for participantsNCT06277427What this trial is testingRefractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T CellsWho this might be right forLupus NephritisANCA Associated Vasculitis Lingli Dong 24
Not applicableUnknownNCT05691179What this trial is testingCOVID-19 Infection and Idiopathic Membranous NephropathyWho this might be right forIdiopathic Membranous Nephropathy Beijing Friendship Hospital 130